Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders

In the light of the emerging new data, the view of the hypothalamic-pituitary-adrenal-target organs system undergoes significant changes, and along with the negative feedback mechanism, there are suggestions of the existence of other regulatory mechanisms for synthesis, activation, and deactivation...

Full description

Bibliographic Details
Main Author: Ekaterina V. Artemova
Format: Article
Language:English
Published: Endocrinology Research Centre 2017-09-01
Series:Ожирение и метаболизм
Subjects:
Online Access:https://endojournals.ru/index.php/omet/article/view/8791
id doaj-8a5c6280c7b24fb587ff43ef7e37331d
record_format Article
spelling doaj-8a5c6280c7b24fb587ff43ef7e37331d2021-10-02T16:10:12ZengEndocrinology Research CentreОжирение и метаболизм2071-87132306-55242017-09-01142485210.14341/omet2017248-527865Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disordersEkaterina V. Artemova0<p>ФГБУ Эндокринологический научный центр Минздрава России</p>In the light of the emerging new data, the view of the hypothalamic-pituitary-adrenal-target organs system undergoes significant changes, and along with the negative feedback mechanism, there are suggestions of the existence of other regulatory mechanisms for synthesis, activation, and deactivation of glucocorticosteroids (GCS). However, there is currently a relatively small amount of data on the relationship between systemic and local cortisol production in tissues. The inconsistent increase in the number of patients with diabetes mellitus (predominantly type 2) and obesity poses new challenges in developing effective medicines and their delivery forms, Methods of timely detection and prevention of the development of the disease. Understanding these processes will create the necessary scientific basis for the search and development of new targets for the pharmacotherapy of diseases associated with a violation of synthesis, activation and action of GCS.https://endojournals.ru/index.php/omet/article/view/8791Кортизолвненадпочечниковая продукциянеоваскулогенезкардиоваскулярные рискирепарация тканей
collection DOAJ
language English
format Article
sources DOAJ
author Ekaterina V. Artemova
spellingShingle Ekaterina V. Artemova
Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders
Ожирение и метаболизм
Кортизол
вненадпочечниковая продукция
неоваскулогенез
кардиоваскулярные риски
репарация тканей
author_facet Ekaterina V. Artemova
author_sort Ekaterina V. Artemova
title Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders
title_short Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders
title_full Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders
title_fullStr Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders
title_full_unstemmed Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders
title_sort synthesis, activation and deactivation of glucocorticoids. the biological role of cortisol in metabolic disorders
publisher Endocrinology Research Centre
series Ожирение и метаболизм
issn 2071-8713
2306-5524
publishDate 2017-09-01
description In the light of the emerging new data, the view of the hypothalamic-pituitary-adrenal-target organs system undergoes significant changes, and along with the negative feedback mechanism, there are suggestions of the existence of other regulatory mechanisms for synthesis, activation, and deactivation of glucocorticosteroids (GCS). However, there is currently a relatively small amount of data on the relationship between systemic and local cortisol production in tissues. The inconsistent increase in the number of patients with diabetes mellitus (predominantly type 2) and obesity poses new challenges in developing effective medicines and their delivery forms, Methods of timely detection and prevention of the development of the disease. Understanding these processes will create the necessary scientific basis for the search and development of new targets for the pharmacotherapy of diseases associated with a violation of synthesis, activation and action of GCS.
topic Кортизол
вненадпочечниковая продукция
неоваскулогенез
кардиоваскулярные риски
репарация тканей
url https://endojournals.ru/index.php/omet/article/view/8791
work_keys_str_mv AT ekaterinavartemova synthesisactivationanddeactivationofglucocorticoidsthebiologicalroleofcortisolinmetabolicdisorders
_version_ 1716852740522508288